Fabricator: Dragon Pharma, Europe
Unit: x1 kit
Strength: 20iu/vial (10 vials)
If your order hasn’t arrived within 35 days after shipping, we’ll resend it for free.
Dragontropin HGH delivers 200 IU of recombinant human growth hormone across ten lyophilized vials. Each vial contains 20 IU of pure Somatropin, identical in structure to endogenous somatotropin produced by the anterior pituitary.
Manufactured through recombinant DNA technology, this agent promotes cellular regeneration, lipolysis, and protein synthesis throughout the entire body. It extends beyond traditional anabolic steroids by stimulating systemic growth and metabolic optimization.
Somatropin is a 191-amino-acid polypeptide hormone critical for tissue repair, skeletal growth, and metabolic regulation. Recombinant production ensures absolute structural identity to native human growth hormone without contamination risk.
The compound mobilizes stored triglycerides from adipose tissue, particularly visceral and abdominal depots. It also stimulates insulin-like growth factor 1 production in the liver, driving hypertrophy and hyperplasia in skeletal muscle.
Collagen synthesis increases under HGH influence. This strengthens connective tissue, improves dermal elasticity, and accelerates healing of tendons, ligaments, and joint structures.
Dragon Pharma packages the lyophilized powder in sealed vials to ensure maximum stability and potency. Reconstitution with bacteriostatic water is required prior to parenteral administration.
Each vial contains 20 IU of Somatropin as the active pharmaceutical ingredient.
The lyophilized formulation includes mannitol and buffering salts to preserve structural integrity during storage and reconstitution. Bacteriostatic water is required for reconstitution prior to injection.
All production batches undergo rigorous quality control for purity, endotoxin levels, and biological potency.
Reconstitute the lyophilized powder by slowly injecting bacteriostatic water along the inner wall of the vial. Swirl gently to dissolve. Never shake vigorously, as this can denature the peptide structure.
Administer via subcutaneous injection into the abdominal fat pad, anterior thigh, or gluteal region. Rotate sites daily to prevent lipoatrophy and localized tissue irritation.
Split the daily total into two administrations, typically morning and post-workout. This mimics natural pulsatile release and maintains stable insulin-like growth factor 1 levels.
Store unopened vials in refrigeration between 2–8°C (36–46°F). After reconstitution, use within 14–28 days depending on preservative content. Never freeze reconstituted solution.
Wellness and anti-aging protocols typically utilize 2–3 IU daily. This supports general rejuvenation, modest fat loss, and improved sleep quality.
Intermediate bodybuilding and performance applications range from 4–6 IU daily. This optimizes body recomposition, accelerates recovery, and stimulates meaningful lean tissue development.
Advanced competitive protocols may reach 6–10 IU daily or higher. These doses require careful monitoring for metabolic side effects and should only be attempted by experienced users.
Protocols should extend for a minimum of 6 months. Twelve-month cycles represent the gold standard for transformative physiological changes, as HGH effects accumulate gradually over time.
Peripheral edema and carpal tunnel syndrome are common initial complaints. Fluid retention in the extremities causes swollen hands and tingling fingers, typically subsiding as the body adapts.
Hyperglycemia and insulin resistance may develop. Regular blood glucose monitoring is essential. Supplements such as berberine or metformin may support glycemic control during extended protocols.
Mild joint and bone discomfort can emerge as connective tissue and skeletal structures respond to growth signals. These sensations are generally transient.
Long-term abuse at supraphysiological doses may produce acromegalic features. Jaw thickening, hand enlargement, and facial bone growth are avoidable through conservative dosing.
Thyroid hormone conversion may be suppressed. HGH can reduce peripheral T4-to-T3 conversion, potentially necessitating exogenous thyroid support based on blood work.
This product is intended exclusively for research purposes and use by qualified adults under appropriate medical supervision. It is not suitable for minors, pregnant or nursing women, or individuals with active malignancy, diabetic conditions, or intracranial hypertension.
Regular monitoring of fasting blood glucose, hemoglobin A1c, and thyroid panels is mandatory during extended protocols. Adjust dosing based on objective metabolic markers.
Maintain a diet moderate in carbohydrates and rich in fiber to support insulin sensitivity. Regular cardiovascular exercise complements the metabolic effects of growth hormone.
Discontinue immediately and seek medical evaluation if severe headaches, visual disturbances, persistent joint swelling, or uncontrolled hyperglycemia develop.
Always use sterile technique during reconstitution and injection. Never share vials or injection equipment.
Please log in to write Dragontropin 200IU GOLD EDITION review.
HGH is a peptide hormone, not a steroid. It stimulates growth and regeneration through IGF-1 mediation rather than direct androgen receptor binding.
It produces gradual, quality tissue gains without the rapid water retention or severe hormonal suppression associated with traditional anabolics.
Subjective improvements in sleep, recovery, and energy often appear within the first 2–4 weeks.
Visible body composition changes typically require 8–12 weeks, with transformative results accumulating over 6–12 months.
HGH should be administered separately from oil-based anabolic compounds. Mixing different formulations can compromise peptide stability and absorption.
Unopened lyophilized vials should remain refrigerated at 2–8°C. After reconstitution, continued refrigeration is mandatory and the solution should be used within 14–28 days.
No. HGH does not suppress the hypothalamic-pituitary-gonadal axis. It can be used without the mandatory Post-Cycle Therapy required after anabolic steroid cessation.
However, if stacked with suppressive compounds, standard PCT for those agents remains necessary.